Andrew L. Pearlman
2010
In 2010, Andrew L. Pearlman earned a total compensation of $1.9M as President and Chief Executive Officer at Medgenics, a 534% increase compared to previous year.
Compensation breakdown
| Bonus | $88,750 |
|---|---|
| Option Awards | $1,426,472 |
| Salary | $308,845 |
| Other | $50,443 |
| Total | $1,874,510 |
Pearlman received $1.4M in option awards, accounting for 76% of the total pay in 2010.
Pearlman also received $88.8K in bonus, $308.8K in salary and $50.4K in other compensation.
Rankings
In 2010, Andrew L. Pearlman's compensation ranked 3,267th out of 10,439 executives tracked by ExecPay. In other words, Pearlman earned more than 68.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,267 out of 10,439 | 69th |
Division Manufacturing | 1,143 out of 3,838 | 70th |
Major group Chemicals And Allied Products | 223 out of 921 | 76th |
Industry group Drugs | 121 out of 680 | 82nd |
Industry Biological Products, Except Diagnostic Substances | 25 out of 142 | 82nd |
Source: SEC filing on August 18, 2011.
Pearlman's colleagues
We found four more compensation records of executives who worked with Andrew L. Pearlman at Medgenics in 2010.